Try our beta test site
515 studies found for:    Open Studies | "Melanoma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Melanoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Prospective Melanoma Database
Condition: Melanoma
Intervention: Other: clinical biological data collection on melanoma
2 Recruiting Characterization of the Melanoma-Specific Immune Response
Condition: Melanoma
Intervention:
3 Recruiting Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Condition: Melanoma
Intervention:
4 Recruiting A Clinical Trial of Patients With Melanoma
Condition: Melanoma
Interventions: Drug: Digoxin Combination;   Drug: Dabrafenib;   Drug: Trametinib
5 Recruiting A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Metformin
6 Recruiting Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas
Condition: Melanoma
Intervention: Radiation: Protontherapy
7 Recruiting A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)
Condition: Melanoma
Interventions: Drug: pembrolizumab + epacadostat;   Drug: pembrolizumab + placebo
8 Recruiting In Vivo Real-time Detection of Circulating Melanoma Cells
Condition: Melanoma
Intervention:
9 Recruiting Treatment of Advanced Melanoma With MK-3475 and Peginterferon
Condition: Melanoma
Interventions: Drug: MK-3475;   Drug: Peginterferon alfa-2b
10 Recruiting BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: BGB324+pembrolizumab;   Drug: BGB324+dabrafenib and trametinib;   Drug: pembrolizumab;   Drug: dabrafenib and trametinib
11 Recruiting Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Condition: Melanoma
Interventions: Drug: Dabrafenib;   Drug: Trametinib;   Drug: Metformin
12 Recruiting A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
Condition: Melanoma
Intervention: Drug: SHR6390
13 Recruiting A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Condition: Melanoma
Interventions: Biological: Poly-ICLC;   Biological: Peptides
14 Not yet recruiting Tracing Dissemination of Melanoma Cells in Healthy Tissues
Condition: Melanoma
Intervention: Procedure: Melanoma and peritumoral skin excision
15 Recruiting Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
Condition: Melanoma
Intervention: Drug: regorafenib
16 Recruiting Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma
Condition: Malignant Melanoma
Intervention:
17 Recruiting A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
Condition: Melanoma
Intervention: Biological: NKT cells
18 Recruiting PLX3397 KIT in Acral aNd mucOsal Melanoma
Condition: Malignant Melanoma
Intervention: Drug: PLX3397
19 Recruiting Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma
Condition: Metastatic Melanoma
Interventions: Drug: Tremelimumab;   Drug: MEDI3617
20 Recruiting Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors
Condition: Metastatic Melanoma
Intervention: Drug: Anti-B-RAF

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.